McNamara To Lead GSK’s Standalone Consumer Healthcare Business

Following a six month selection process, GSK has named Brian McNamara as CEO designate of its standalone Consumer Healthcare business, which will list on the London Stock Exchange next year.

Munich, Bavaria / Germany - May 19, 2018: Headquarters of GlaxoSmithKline GmbH & Co. KG in Munich, Germany - GSK is a British pharmaceutical company
• Source: Shutterstock

Brian McNamara will lead GlaxoSmithKline’s standalone Consumer Healthcare business when it launches in summer 2022.

CEO of GSK’s Consumer Healthcare division since October 2016, McNamara has been named CEO designate of the new, listed Consumer Healthcare company, securing the

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on HBW Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Leadership

US FDA Restoring Some Library Resources

 

Agency staff once again have access to the Lexis-Nexis legal and news database, but are still waiting for access to journals, and laid off librarians have not been reinstated.

People On The Move: Appointments at Opella, NèreS, Haleon

 
• By 

A round-up of the latest consumer health industry moves: Opella names France head; NèreS elects president; Haleon has new Saudi GM.

US Consumer Health Executive News: CHPA Regulatory SVP, Kenvue CFO, PLT Sales Head

 

Former FDA OTC division director joins CHPA; PLT Health names global sales chief; and Kenvue loses CFO to Mattel, hires replacement from Kellanova.

People On The Move: Appointments At Haleon, Wellnex, Orkla

 
• By 

A round-up of the latest consumer health leadership changes: Haleon names Middle East & Africa unit manager; Wellnex Life appoints interim chair; Orkla Health appoints CEO.

More from HBW Insight

US FDA Restoring Some Library Resources

 

Agency staff once again have access to the Lexis-Nexis legal and news database, but are still waiting for access to journals, and laid off librarians have not been reinstated.

Kennedy’s Balancing Act: Push MAHA, Trim Regs

 

Same-day announcements of RFIs from HHS secretary cover nutrient review process for infant formula and Kennedy’s “10-to-1 deregulatory policy” as part of president’s “broader federal effort to reduce regulatory burdens and increase transparency.”

People On The Move: Appointments at Opella, NèreS, Haleon

 
• By 

A round-up of the latest consumer health industry moves: Opella names France head; NèreS elects president; Haleon has new Saudi GM.